GlassScriptPhysician profile
Amy N Barnes
NPI 1770983090
$993.12
in general payments reported to CMS, 2019-2025
14 companies · $387 in 2025
The $387 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $135 · 2022: $80.59 · 2023: $115 · 2024: $276 · 2025: $387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $778.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $777.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $192.86 | 2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $190.79 | 2024-2025 | Caplyta |
| Axsome Therapeutics, INC. | $168.56 | 2025 | Auvelity |
| Idorsia Pharmaceuticals US INC | $115.47 | 2023 | Quviviq |
| Janssen Pharmaceuticals, INC | $99.79 | 2021-2025 | Spravato |
| Zimmer Biomet Holdings, INC. | $50.31 | 2024 | Ribfix Blu Advantage |
| Lundbeck LLC | $49.93 | 2021 | |
| Boston Scientific Corporation | $27.30 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $24.13 | 2021 | |
| Collegium Pharmaceutical, INC. | $23.35 | 2025 | Jornay Pm |
| Alkermes, INC. | $19.48 | 2022 | |
| Vanda Pharmaceuticals INC. | $13.85 | 2024 | Hetlioz, Fanapt |
| Neurocrine Biosciences, INC. | $12.55 | 2021 | |
| Corium, LLC | $4.75 | 2025 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Barnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.